Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence study of two 25 mg pregabalin capsule formulations in healthy Thai volunteers under fasting conditions
TCTR20230208004Phase 1Unknown
- Sponsor
- Faculty of Medicine Siriraj Hospital, Mahidol University
- Start
- Sep 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label trial of pregabalin (2 arms), sponsored by Faculty of Medicine Siriraj Hospital, Mahidol University. Primary endpoint: Pharmacokinetic blood concentrations over 0 to 24 hours after dosing. Status: unknown.
02
Drugs
pregabalin
Beyond the preview
Go deeper on TCTR20230208004.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20230208004.